Concerto Biosciences

About

Concerto Biosciences is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020. The company focuses on developing microbe-based products for various applications, including dermatology, women's health, agriculture, food, skincare, chronic disease, and nutrition. It utilizes its proprietary kChip discovery platform and kAI models to create innovative solutions that enhance human health and environmental sustainability. The kChip is a high-throughput coculture screening device that analyzes millions of microbial communities, generating extensive datasets on microbial interactions. This data informs the kAI model, which predicts microbial behavior and aids in the development of microbial community "ensembles" and other products. Concerto is actively seeking partnerships for co-development, out-licensing, and investment to advance its clinical-stage products and expand its pipeline.